NovaBridge Biosciences American Depositary Shares (NBP)

Price$1.71

Growth ScoreF

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-72.02%

Price vs S&P 500 (4W)-27.66%

VGM Score27.73

Market Capitalization$212.30M

All Metrics

Book Value / Share (Quarterly)$0.87

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-73.83%

Cash Flow / Share (Quarterly)$-0.08

Price vs S&P 500 (YTD)-64.70%

Gross Margin (TTM)100.00%

Net Profit Margin (TTM)-439.76%

EPS (TTM)$-0.19

10-Day Avg Trading Volume0.82M

EPS Excl Extra (TTM)$-0.19

Revenue Growth (5Y)-12.47%

EPS (Annual)$-0.21

ROI (Annual)-20.03%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-1791.81%

Cash / Share (Quarterly)$0.79

ROA (Last FY)-17.76%

EBITD / Share (TTM)$-0.32

ROE (5Y Avg)-50.80%

Operating Margin (TTM)-416.50%

Cash Flow / Share (Annual)$-0.08

P/B Ratio0.92x

P/B Ratio (Quarterly)1.98x

Net Income / Employee (Annual)$-1,542,300

Net Interest Coverage (TTM)-6.29x

ROA (TTM)-19.41%

EPS Incl Extra (Annual)$-0.21

Current Ratio (Annual)8.09x

Quick Ratio (Quarterly)8.06x

3-Month Avg Trading Volume0.86M

52-Week Price Return46.03%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)7.68x

Asset Turnover (Annual)0.07x

52-Week High$6.79

Operating Margin (5Y Avg)-1670.60%

EPS Excl Extra (Annual)$-0.21

CapEx CAGR (5Y)-75.54%

26-Week Price Return-56.09%

Quick Ratio (Annual)8.06x

13-Week Price Return-43.90%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)8.09x

Enterprise Value$1.67M

Revenue / Share Growth (5Y)-18.84%

Asset Turnover (TTM)0.11x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-297.41%

Cash / Share (Annual)$0.79

3-Month Return Std Dev69.15%

Net Income / Employee (TTM)$-1,542,300

ROE (Last FY)-20.03%

Net Interest Coverage (Annual)-2.57x

EPS Basic Excl Extra (Annual)$-0.21

Receivables Turnover (TTM)-1.54x

EV / Free Cash Flow (TTM)0.85x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.19

Receivables Turnover (Annual)-1.54x

ROI (TTM)-20.91%

P/S Ratio (TTM)4.49x

Pretax Margin (5Y Avg)-1700.94%

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)17.83%

Year-to-Date Return-53.77%

5-Day Price Return3.95%

EPS Normalized (Annual)$-0.21

ROA (5Y Avg)-37.54%

Net Profit Margin (Annual)-751.44%

Month-to-Date Return-25.51%

EBITD / Share (Annual)$-0.43

Operating Margin (Annual)-260.52%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-50.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.19

P/B Ratio (Annual)1.98x

Pretax Margin (TTM)-439.76%

Book Value / Share (Annual)$0.87

Price vs S&P 500 (13W)-53.65%

Beta1.46x

P/FCF (Annual)0.50x

Revenue / Share (TTM)$0.00

ROE (TTM)-20.91%

52-Week Low$1.20

gGradeF

mGradeD

vgmGradeD

Show chart for

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.30

4.22

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
NBPNovaBridge Biosciences American Depositary Shares	—	F	D	$1.71
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

NovaBridge Biosciences is a biotechnology company that identifies and develops pharmaceutical assets, combining clinical research with strategic business development to advance therapies toward commercialization. The company's pipeline includes Givastomig, VIS-101, Ragistomig, and Uliledlimab.